| Dorsal Raphe Nucleus Serotonergic Projection Neurons | |
|---|---|
| Allen Atlas ID | CS202210140_3603 |
| Lineage | Neuron > Serotonergic > Raphe nucleus > Dorsal raphe |
| Markers | TPH2, SLC6A4 (SERT), SLC22A3 (OCT3), HTR1A, HTR2A |
| Brain Regions | Dorsal raphe nucleus (midbrain), Forebrain targets |
| Disease Vulnerability | Alzheimer's Disease, Parkinson's Disease, Depression, Migraine |
Dorsal Raphe Nucleus Serotonergic Projection Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The dorsal raphe nucleus (DRN) is the largest serotonergic cell group in the brain and provides the majority of forebrain serotonergic innervation [1]. Serotonergic projection neurons from the DRN modulate virtually every aspect of brain function, including mood, cognition, sleep, appetite, and pain perception [2]. These neurons are clinically significant due to their involvement in depression, anxiety, and neurodegenerative diseases.
The DRN is strategically positioned in the midbrain raphe and projects to widespread forebrain targets including the cortex, hippocampus, amygdala, basal ganglia, and hypothalamus. This extensive projection pattern allows serotonin to serve as a global neuromodulator of brain state.
The dorsal raphe nucleus is located in the midbrain:
The DRN contains multiple subregions:
DRN serotonergic neurons project to:
DRN serotonergic neurons are central to mood [3]:
Serotonin modulates cognitive processes:
DRN activity varies with arousal state:
Serotonergic system in pain processing:
Serotonin regulates feeding:
DRN serotonergic neurons exhibit:
DRN involvement in AD includes [4]:
Serotonergic changes in PD [5]:
Bidirectional relationship with neurodegeneration:
Dorsal Raphe Nucleus Serotonergic Projection Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Dorsal Raphe Nucleus Serotonergic Projection Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Dorsal raphe nucleus circuitry in mood disorders. Nat Neurosci, 2018.
Serotonin and cognitive function. Trends Cogn Sci, 2019.
Serotonergic system in Alzheimer's disease. Acta Neuropathol, 2019.
Dorsal raphe and Parkinson's disease. Parkinsonism Relat Disord, 2019.
5-HT receptors as therapeutic targets. Pharmacol Ther, 2019.